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Socioeconomic status (SES) is a multi-dimensional construct
that is used as an indicator of environmental influences on health
and well-being [1–7]. A sociological approach to understanding
the importance of SES for health outcomes may be informative.
The idea of capital, broadly defined as resources and assets that
affect well-being on an individual or group level, is derived from
conventional measures of SES but incorporates the critical di-
mension of social relationships. Specifically, access to material
resources (financial capital), non-material resources (human
capital) and social relationships (social capital) may converge to
influence health and well-being, but represent distinct resources
[8–9].
Although it is preferable to measure multiple dimensions of
SES, investigators often use a single measure, such as income.
Braverman and others [10–12] have maintained that although
SES measures are moderately correlated, they are neither inter-
changeable nor robust independent proxies for SES. Bauman
et al. [1] examined the impact of social disadvantage on child
health. Social disadvantage was defined by four risk factors that
are commonly used as SES measures: race/ethnicity, income,
parental education, family structure. While each factor was in-Abbreviations: CF, cystic fibrosis; LME, longitudinal mixed effects model;
PI, pancreatic insufficiency; SES, socio-economic status.
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doi:10.1016/j.jcf.2008.06.004dependently related to overall risk of poor health, only income,
parental education and family structure were related to other
health outcomes, namely the presence of a chronic medical
condition, and to the presence of limited activity.
Cystic fibrosis (CF) is the most common genetic disease in
children of European descent in the US, with variable effects on
pulmonary function and growth. Using data from the US CF
Registry, two studies have investigated the impact of income on
health outcomes in children with CF [13–14]. Investigators re-
ported a significantly higher risk of death, growth faltering and
reduced pulmonary function in children from lower versus
higher income families. The effects of other dimensions of SES
were not examined.
The aim of this study was to explore the impact of SES on
children with CF using a sociological approach. We examined
the relationship between financial, human and social capital and
growth and pulmonary status in preadolescent children with CF
and pancreatic insufficiency (PI) over 24 months. For the pur-
pose of this study, financial capital was defined as household
income, human capital as primary caregiver education and social
capital as family structure, specifically the number of caregivers
in the household.
2. Materials and methods
2.1. Subjects
Subjects consisted of preadolescent children who participated
in a prospective cohort study of growth, nutrition and pulmonary
status. At enrollment, children were ages 6.0 to 8.9 years and hadd by Elsevier B.V. All rights reserved.
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from 13 CF Centers in the United States and followed for
24 months. The diagnosis of CF and PI were made at the home
CF Center by clinical symptoms and duplicate quantitative pilo-
carpine iontophoresis sweat tests with chloride greater than
60 mEq/L, and 72-hour fecal fat analysis showing less than 93%
absorption or a stool trypsin of less than 80 μg/g. Subjects were
excluded if they had poor lung function (FEV1 percent predicted
b40%), liver disease, insulin-dependent diabetes mellitus, Bur-
kholderia cepacia sputum colonization or growth-impairing
medical conditions.
The protocol was approved by the Committee for the
Protection of Human Subjects of the Institutional Review
Board at Children's Hospital of Philadelphia and by the subjects'
home institution. Informed, written consent was obtained from
the parent or legal guardian; age-appropriate assent was obtained
from each subject. Study visits were conducted at baseline, 6, 12,
18 and 24 months.
2.2. Advantage Index
In the absence of an existing measure, we devised an index
that was influenced by our framework for understanding SES.
We included an indicator of financial capital (household in-
come), human capital (caregiver education) and social capital
(caregiver status) to reflect different types of capital. Household
income, primary caregiver's highest level of education and
caregiver status were obtained by a questionnaire completed by
the primary caregiver at baseline. Three levels of income were
analyzed: less than $20,000, $20,000 to $74,999 and N$75,000.
Three levels of education were analyzed: less than high school,
completed high school but not college, and completed college
or above. Caregiver status was reported as mother, father and/or
guardian (including grandparent) and whether they lived with
the child. Type of insurance, including Medicaid, was also
obtained by caregiver report at baseline. School days missed
and hospitalizations were monitored throughout the study.
For the Advantage Index, children were categorized into
groups based on social risk factors (see Fig. 1). Cut points were set
to reflect extremes of income: b$20,000 (federal poverty level)
and N$75,000 (highest level of income recorded). For education,
cut points were set to distinguish between common levels of
schooling in the US, specifically the completion of high school
and the completion of college. Caregiver status was determined
based on single versus dual caregivers in the household. Children
were included in the Social Advantage group if they met all
criteria: household income N$75,000, primary caregiver with atFig. 1. Advantageleast a college degree and dual caregivers. Childrenwere included
in the Social Disadvantage group if they had any one of the
following social risk factors: household income b$20,000,
primary caregiver education less than high school or a single
caregiver. Thus, having any social risk factor (low income, limited
primary caregiver education or single caregiver) offset the
advantage of higher income, higher education or dual caregiver.
Children in the No Social Disadvantage group had none of these
social risk factors, but did not meet all criteria for inclusion in the
Social Advantage group. For example, a childwith two caregivers
and a household income N$75,000, but whose primary caregiver
did not have a college degree, was included in the No Social
Disadvantage group.
2.3. Anthropometric measures
Weight and height were measured at all study visits using
standard techniques [15], a scale accurate to 0.1 kg (Scaletronix,
White Plain, NY) and a stadiometer accurate to 0.1 cm (Holtain,
Crymych, UK). Body mass index (BMI; weight (kg)/height
(cm2)) was calculated. Parental height was collected for both
biologic parents and used to obtain a mid-parent height [16].
The mid-parent height and subject's height were then used to
calculate an adjusted height. Z scores for weight (WAZ),
adjusted height (AHAZ) and body mass index (BMIZ) were
calculated [17].
2.4. Pulmonary disease
FEV1 was measured by spirometry at baseline, 12 and
24 months, following administration of inhaled albuterol and
chest physiotherapy [18–19]. FEV1 (% predicted) was calcu-
lated using the Wang equation [20].
2.5. Statistical analysis
Data analysis included both descriptive and inferential
statistics. Baseline comparisons of continuous variables (age,
growth and pulmonary status) by Advantage Index groups were
performed by ANOVA, with post hoc student's t tests for
individual group comparisons. For data that was not normally
distributed, group differences were determined using Wilcoxon
rank sum test.
Longitudinal mixed effects (LME) analysis [21] was used to
determine whether financial, human or social capital groups,
when considered separately and then combined into Advantage
Index groups, predicted growth status (AHAZ, WAZ andIndex groups.
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LME analysis was also used to determine if Advantage Index
groups predicted growth and pulmonary status. LME models
allow for the estimation of fixed effects such as Advantage
Index group or types of capital, initial age, gender and random
effects such as changing values of growth and pulmonary status
over time. For growth status, all five time points (baseline, 6, 12,
18 and 24 months) were included in the LME analysis. For
pulmonary status, three times points (baseline, 12 and
24 months) were included.
Initial age at baseline and gender (with females as the
reference group) were entered as fixed effects in each model to
account for baseline age and gender differences in growth and
pulmonary status. Time (in years) was entered into each model;
the coefficient for time represents the annual change in growth
or pulmonary status. In testing whether or not the Advantage
Index groups predicted outcomes in these LME models, the
Social Disadvantage group is the reference group. The ability of
the each of the types of capital (financial, human, social) to
predict outcomes was tested in separate models, with b$20,000
as the reference group for financial capital, less than high school
education as the reference group for human capital, and single
caregiver as the reference group for social capital. The inter-Table 1
Baseline characteristics of the total sample and by Advantage Index groups
Advantage Index group
Total 1 Social disadvan
Number 77 17
Age, yr 7.2±0.9 7.0±0.9
Race, non-Caucasian 2 (3) 0 (0)
Male 35 (45) 8 (47)
Adjusted height Z score⁎ −0.8±1.0 −1.0±1.1
Weight Z score⁎ −0.5±1.1 −0.8±1.1 c
BMI Z score −0.2±1.1 −0.1±1.0
FEV1, % predicted
† 99±18 94±16 c
Genotype
ΔF508/ΔF508 43 (56) 9 (53)
ΔF508/other 28 (36) 7 (41)
Other/other 6 (8) 1 (6)
Hospitalizations per yr, #
Total CF-related 1.1±1.8 1.4±2.5
Pulmonary only 0.8±1.4 0.8±1.1
Schools days missed†
Per 24 mo 14±17 23±24 c
1° caregiver education, %
NCollege degree 29 (39) 1 (7)
bHigh school degree 4 (5) 4 (27)
Income, %
N$75,000 30 (39) 2 (12)
b$20,000 6 (8) 6 (35)
Available caregivers, %
Dual 67 (87) 7 (38)
Single 10 (13) 10 (62)
Medicaid, % 10 (14) 5 (38)
Data are presented as mean+SD or n (%).
*pb0.01.
† pb0.05.
1 n=76 for AHAZ, n=75 for 1° caregiver education and available caregivers, n=
a Significantly different from social disadvantage.
b Significantly different from no social disadvantage.
c Significantly different from social advantage.action terms for group× time are terms of particular interest in
the models, as they indicate the difference between groups in
the annual rate of change in growth or pulmonary status over the
24 month period. For each of the group comparisons, a total of
four separate models were tested for statistical significance:
three growth status outcomes and one pulmonary status
outcome. The experiment-wise error rate was held constant at
the α=0.05 level across all four models, with an hypothesis-
wise error rate of α=0.02 for each of the four related models,
separately, using the Tukey, Ciminera and Heyse's adjustment
for multiple, highly related comparisons [22–23]. Data were
analyzed using STATA 7.0, 2002 (STATA Corporation, College
Station, TX).
3. Results
Of the 86 preadolescent children who completed the 24 month
study, social risk data were available for 77 (45% male) with
average age 7.2+0.9 years; 97% of the children were Caucasion.
The main reason for incomplete data was lack of household
income in nine families. These children did not differ from the 77
with complete data in age, gender, AHAZ, BMIZ or pulmonary
function. They were more likely to have a better WAZ (pb0.05).tage No social disadvantage Social advantage
41 19
7.2±0.9 7.5±1.0
1 (2) 2 (5)
19 (46) 8 (42)
−1.0±0.7 c −0.2±1.3 b
−0.7±0.9 c 0.1±1.1 a, b
−0.4±1.1 0.1±0.9
99±19 106±17 a
25 (61) 9 (47)
13 (32) 8 (42)
3 (7) 2 (11)
1.1±1.7 0.6±1.1
0.9±1.7 0.5±0.8
14±15 10±14 a
9 (22) 19 (100)
0 (0) 0 (0)
9 (22) 19 (100)
0 (0) 0 (0)
41 (100) 19 (100)
0 (0) 0 (0)
5 (13) 0 (0)
74 for FEV1, n=70 for Medicaid, and n=63 for school days missed per 24 mo.
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sample and by Advantage Index group are presented in Table 1.
Children in the Social Disadvantage and No Social Disadvan-
tage groups had suboptimal growth status, with AHAZ and
WAZ ranging from −0.7 to −1.0, while children in the Social
Advantage group had Z scores close to 0, indicating normal
growth status. Although there was a trend for FEV1 to increase
in a stepwise fashion from Social Disadvantage to No Social
Disadvantage to Social Advantage groups, only the difference
between the Social Advantage and Social Disadvantage groups
was significant based upon a post hoc student t test (106 vs.
94% predicted, p=0.04). Neither genotype nor hospitalizations
differed among groups. However, children in the Social Ad-
vantage group had significantly fewer School Days Missed than
children in the Social Disadvantage group.Table 2
Longitudinal mixed effects model analysis of Advantage Index predicting
growth outcomes
Coefficient Wald
P
Observations Overall
R2
P
(model)
Adjusted height Z score
No social
disadvantage
−0.02 (0.29) .956 367 .133 .016
Social advantage 0.83 (0.33) .013
Time, yr 0.01 (0.12) .931
No social
disadvantage× time
0.06 (0.03) .071
Social
advantage× time
0.08 (0.04) .047
Constant −0.48 (0.91) .601
Weight Z score
No social
disadvantage
0.06 (0.30) .848 373 .198 .003
Social advantage 1.08 (0.34) .002
Time, yr 0.14 (0.13) .292
No social
disadvantage× time
0.09 (0.05) .052
Social
advantage× time
0.06 (0.05) .261
Constant 0.45 (0.93) .627
BMI Z score
No social
disadvantage
−0.20 (0.28) .480 373 .135 .008
Social advantage 0.47 (0.33) .148
Time, yr 0.03 (0.13) .821
No social
disadvantage× time
0.16 (0.06) .008
Social
advantage× time
0.15 (0.07) .041
Constant 0.75 (0.88) .394
FEV1 percent predicted
No social
disadvantage
4.95 (2.97) .297 217 .05 .004
Social advantage 11.37 (5.53) .040
Time, yr −1.37 (2.41) .568
No social
disadvantage× time
−1.04 (1.82) .567
Social
advantage× time
−3.31 (2.12) .119
Constant 95.40 (14.17) .000
Fig. 2. Trends in growth status (AHAZ, WAZ, BMIZ; mean±SEM) over the 24
month study period for Advantage Index groups.By design, all children in the Social Advantage group had a
household income N$75,000, a primary caregiver with a college
degree and dual caregivers in the household. For the No Social
Disadvantage group, 22% lived in households with the highest
income category and 22% had primary caregivers with college
degrees; all lived in a dual caregiver household. For the Social
Disadvantage group, where only one social risk factor was
necessary for inclusion, 59% lived in single caregiver house-
holds, 24% had a primary caregiver with less than a high school
education and 35% had household incomes b$20,000. None of
the children in the Social Advantage group received Medicaid,
while 13% in the No Social Disadvantage group and 38% of the
Social Disadvantage group were enrolled in Medicaid.
LME models evaluating differences in growth status
(AHAZ, WAZ, BMIZ) and FEV1 over the 24 month period
between types of capital and Advantage Index groups were
constructed. The LME models for the Advantage Index groups
predicting growth and pulmonary outcomes are presented in
Table 2. The Advantage Index combines all types of capital
Fig. 3. Trends in pulmonary status (FEV1; % predicted) over the 24 month study
period for Advantage Index groups.
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group× time interactions represent annual change in Z score for
each variable, with initial age and gender (females are reference
group) as fixed effects. There were no significant age or gender
effects (coefficients not presented in Table 2).
Using the Advantage Index which combines all three types
of capital (financial, human, social), children in the Social Ad-
vantage group had greater height status than the Social Dis-
advantage reference group overall and this difference increased
over time (Social Advantage× time interaction term). Children
in the Social Advantage group also had better weight status than
children in the Social Disadvantage group overall with no
difference in change over time. Compared to children in the
Social Disadvantage group, those in either the Social Advantage
or No Social Disadvantage group had greater BMI status (re-
lative weight for height) over time. A similar LME model was
tested for FEV1, and while children in the Social Advantage
group had significantly better pulmonary function overall (+11
FEV1 % predicted), there were no group differences in change
over time. All models presented in Table 2 achieved statistical
significance using the more stringent criterion of α=0.02 for
multiple comparisons of highly related outcomes, and explained
13%, 20%, 14% and 5% of the variance for height, weight, BMI
and FEV1 status, respectively.
Similar LME models were run examining the effect of
financial, human and social capital separately on growth and
pulmonary status (results not shown). Although pulmonary
status was not predicted by financial, human or social capital in
these models, growth status was predicted. For financial capital,
the two higher income groups had significantly better height,
weight and BMI status over time than the lowest income group
(b$20,000), although they did not differ at baseline (between 5
and 8% of variance predicted). For human capital, children
whose primary caregivers had college degrees or higher had
significantly better height, weight and BMI status overall than
those whose caregivers had less than high school education
(between 6 and 17% of variance predicted). For BMI, this ad-
vantage increased over time. For social capital, children living
in a dual caregiver household had significantly better height
status over time than those living in a single caregiver house-
hold (between 1 and 5% of variance predicted). Notably, the
Advantage Index which combines the three types of capital
predicted a greater proportion of the variance in growth and
pulmonary outcomes than did any single type of capital alone.
Fig. 2 presents patterns of growth as AHAZ,WAZ, andBMIZ
(mean+standard error of the mean (SEM) over 24 months for
each of the Advantage Index groups. Compared to other
Advantage Index groups, children in the Social Advantage
group had significantly better growth status for all three mea-
sures, and maintained their superior growth over time. Children
in the Social Disadvantage group had poorer growth status at
baseline and a significant decline in status over 24 months
relative to children in the Social Advantage group. Children in
the No Social Disadvantage group had poorer growth status at
baseline relative to children in the Social Advantage group.
However, their status did not worsen over time. For pulmonary
function, children in the Social Advantage group had signifi-cantly better FEV1 than those in the Social Disadvantage group
(Fig. 3). Although FEV1 declined in all three groups over time,
there were no differences in time trends among the groups for
pulmonary function.
4. Discussion
Social disadvantage has adverse effects on the health of
children in the US [1–6]. The evidence presented in this
relatively small number of preadolescent children with mild to
moderate CF lung disease and PI suggests an adverse effect of
social disadvantage on health outcomes. Each social risk factor
examined in this study, i.e. low income, limited education, or
single caregiver, was associated with suboptimal growth and
pulmonary function at baseline or a decline in growth status
over 24 months. The Advantage Index, a composite of three
dimensions of SES, was the strongest predictor of growth status
in this sample.
SES is a complex construct that, for children, generally en-
compasses the assets, resources and support available through
their family and community [8,24]. Bauman et al. [1] used data
on 57,553 children, b18 years or age, in the 1994 and 1995
National Health Interview Survey to assess the impact of social
disadvantage on child health. Social risk factors considered in
that study (family incomes below the federal poverty level; not
living with two biological parents; having a parent whose
highest level of education was high school) increased the child's
risk of poor health, an effect seen when risk factors were
considered alone or in combination.
Taking a sociological approach, we created an index that
accounted for household income (financial capital), caregiver
education (human capital) and family structure (social capital)
to capture different dimensions of SES. In our Advantage Index,
the combination of low income, limited education and single
caregiver status explained 13% of the variability in AHAZ, a
measure of long term growth and health, and 20% of the
variability in WAZ, a measure of short term growth. Although
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differences in BMIZ, AHAZ is a more stable indicator of
growth and serves as a prognostic factor in survival in CF [25].
Our findings corroborate past studies demonstrating an early,
adverse effect of financial capital on children with CF [13–
14,26] Using Medicaid as a proxy for low SES and the 1986 to
1994 US CF Foundation Patient Registry, Schechter et al. [13]
reported that the adjusted risk of death was over three times
higher for children on Medicaid than for those not enrolled in
Medicaid. Pulmonary function was worse, and the likelihood of
falling below the 5th percentile for both weight and height was
greater, for Medicaid versus non-Medicaid patients. This pattern
was evident in young children and persisted over time. In our
study, only 10 subjects were enrolled in Medicaid, evenly split
between the Social Disadvantage and No Social Disadvantage
groups. Using median household income estimated by zip code
of residence reported from 1991 to 2000 in the US CF
Foundation Patient Registry, O'Connor et al. [14] reported a
44% increased risk of death for children with CF who were in
the lowest income group (b$20,000) compared to the highest
income group (N$50,000). Children in the lowest income group
had consistently poorer pulmonary function and weight
percentiles than children in higher income groups. The
differences between higher and lower income groups appeared
early in life and persisted into adulthood.
To our knowledge, this is the first study to examine the effect
of human capital on health outcomes of children with CF. In a
study from South Africa, Henley et al. [27] used an alternate
indicator of human capital, social class, which was determined
by father's occupation. These authors reported a significant
association between social class and mothers' and fathers'
knowledge of CF, but did not investigate the association
between class and health outcomes. Studies of medical therapy
adherence in children with CF and their families have shown
that caregiver knowledge of specific treatment regimens has
variable effects on adherence [28–32]. None, however, have
examined the effect of caregiver's overall level of education on
health outcomes.
Little is known about how family structure, specifically the
number of caregivers available to the child, might influence
health outcomes. In our study, single caregiver was the leading
criteria for inclusion in the Social Disadvantage group. In a
report from Ireland, children with CF who were less than six
years of age and cared for by single mothers, nearly half of
whom were b18 years, had worse outcomes than those with
dual caregivers [33]. The demands of CF treatment are
considerable [34,35]. Because single caregivers, regardless of
age, income or education may experience less support in
meeting their child's health care needs, future research might
consider the needs of the family unit.
Although conceptualizing SES through a sociological lens as
the composite of financial, human and social capital has
widespread applicability in health research, using individual
indicators of the different types of capital has limitations in
terms of construct validity [10–12]. For example, static
measures of household income account for neither accumulated
wealth nor changes in income over time. Moreover, income isconsidered confidential information and may not be readily
disclosed. Level of caregiver education does not address the
quality of education, problem solving ability, or self-confi-
dence. The number of caregivers does not capture the quantity
or quality of social networks within the extended family and
community.
There are some limitations to our study. The sample size led
to relatively small numbers in each Advantage group. There was
some overlap between Social Disadvantage group and No
Social Disadvantage group in terms of growth and hospitaliza-
tions and heterogeneity in the Social Disadvantage group in
terms of human and social capital. There is no validated
measure of capital in a pediatric chronic disease setting. The
creation of the Advantage Index, which combines financial,
human and social capital, was our effort to better understand the
complexity of SES and its impact on health outcomes. Future
studies with larger samples of children with CF are needed to
explore SES factors separately and in combination.
Minority race/ethnicity is a leading risk factor for poor health
in adults and in children in the US [2,4,7,11]. The racial/ethnic
distribution in our sample did not vary enough to warrant
exploring minority status. This should be considered in future
studies with more racially and ethnically diverse CF samples, as
black children with CF may have lower weight, height and
weight-for-height percentiles than white children [36].
Conceptualizing social disadvantage more broadly as financial,
human and social capital revealed a subset of children whose
growth faltered over time despite sufficient financial means.
Alternatively, our findings could be interpreted as showing that
children in the Social Advantage group had better outcomes
compared to children in the No Social Disadvantage or Social
Disadvantage groups. Indeed, the growth status of preadolescent
children with CF who were socially advantaged, as defined by our
Advantage Index, was comparable to a healthy population.
Focusing on the positive effects of Social Advantage on growth
outcomes has merit, but may detract from awareness of low
income, limited education or single caregiver status as potential risk
factors. Notably, any one of these disadvantages predicted poorer
growth despite access to the coordinated, multi-disciplinary care
children received at CF Centers. While there may be a subset of
children who are socially advantaged and doing exceptionally well
compared to others, our study sheds light on the childrenwhomight
most benefit from more intense intervention.
While future research is needed, our data suggest that health
care professionals might target children with CF from single
caregiver households and/or whose primary caregiver has
limited education for more intense instruction, monitoring and
support. Innovative interventions might be developed to in-
crease caregivers' capacity to navigate complex health systems,
and tailor education and counseling to the caregiver's level of
understanding [37]. Community-based, family support pro-
grams, shown to have a positive effect on the psychosocial
adjustment of children with chronic disease including those
with CF, may provide a template for intervening with single
caregiver families [38–39]. The combination of professional
and lay person support may empower caregivers and result in
better health for children with CF [40–42].
549D.F. Balmer et al. / Journal of Cystic Fibrosis 7 (2008) 543–550In summary, preadolescent children with CF who experi-
enced social disadvantage, defined as a composite of low
income, limited caregiver education and single caregiver status,
were more likely than their socially advantaged peers to exhibit
poor growth and pulmonary function by 6 to 8 years of age, and
poorer growth over time. The Advantage Index demonstrates
the importance of considering the whole rather than single types
of capital. Our Advantage Index should be validated, and its
applicability over time and different populations should be
explored. Future intervention studies are needed to determine
how best to alleviate the negative growth effects of social
disadvantage in children with CF.
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